1 5 , ▁the ▁cost ▁for ▁a ▁typical ▁month ▁of ▁medic ation ▁in ▁the ▁United ▁States ▁was ▁more ▁than ▁$ 2 0 0 . ▁ ▁Medical ▁uses ▁Ne vi rap ine ▁is ▁used ▁in ▁adult s ▁and ▁in ▁children ▁ 6 ▁years ▁of ▁age ▁inf ected ▁with ▁H IV - 1 ▁as ▁part ▁of ▁combination ▁ant ire t ro vir al ▁treatment ▁( ART ▁or ▁c ART ). ▁Mon other apy ▁with ▁ne vi rap ine ▁is ▁not ▁indicated ▁due ▁to ▁rapid ▁emer gence ▁of ▁resistance . ▁ ▁Ne vi rap ine ▁in ▁triple ▁combination ▁ther apy ▁has ▁been ▁shown ▁to ▁suppress ▁vir al ▁load ▁effectively ▁when ▁used ▁as ▁initial ▁ant ire t ro vir al ▁ther apy ▁( i . e ., ▁in ▁ant ire t ro vir al - na ive ▁patients ). ▁Some ▁clin ical ▁tri als ▁have ▁demonstrated ▁compar able ▁H IV ▁supp ression ▁with ▁ne vi rap ine - based ▁reg im ens ▁to ▁that ▁achieved ▁with ▁reg im ens ▁based ▁on ▁a ▁prote ase ▁in hib itor ▁( PI ) ▁or ▁e f av ir enz . ▁ ▁This ▁drug ▁is ▁generally ▁only ▁to ▁be ▁considered ▁for ▁use ▁if ▁the ▁CD 4 ▁cell ▁count ▁is ▁very ▁low . ▁ ▁Although ▁concerns ▁have ▁been ▁raised ▁about ▁ne vi rap ine - based ▁reg im ens ▁in ▁those ▁starting ▁ther apy ▁with ▁high ▁vir al ▁load ▁or ▁low ▁CD 4 ▁count , ▁some ▁anal ys es ▁suggest ▁that ▁ne vi rap ine ▁may ▁be ▁effective ▁in ▁this ▁group ▁of